Proxygen Announces Formation of Scientific Advisory Board
15 nov. 2023 07h00 HE
|
Proxygen
SAB Comprised of Pioneers in the Field of Protein Degradation, Including Unique Expertise in Roles of Ubiquitin Biology and Translational Medicine Track Records of Founding Biopharma Companies and...
Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023
28 août 2023 06h00 HE
|
Proxygen
VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s...
Proxygen gibt Kooperation und Lizenzvereinbarung mit MSD für die Entdeckung und Entwicklung neuartiger Molecular Glue Degraders bekannt
05 avr. 2023 10h55 HE
|
Proxygen
WIEN, Österreich, April 05, 2023 (GLOBE NEWSWIRE) -- Proxygen, ein führendes Unternehmen im Bereich der Entdeckung und Entwicklung von Molecular Glue Degraders, gab heute bekannt, dass es eine...
Proxygen annonce un accord de collaboration et de licence avec MSD portant sur la découverte et le développement de nouveaux dégradeurs de colles moléculaires
05 avr. 2023 10h55 HE
|
Proxygen
VIENNE, Autriche, 05 avr. 2023 (GLOBE NEWSWIRE) -- Proxygen, un chef de file dans la découverte et le développement de dégradeurs de colles moléculaires, a annoncé aujourd'hui un accord de...
Proxygen Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Molecular Glue Degraders
05 avr. 2023 07h00 HE
|
Proxygen
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, announced today a multi-year research collaboration and license...
Proxygen Announces Formation of Board of Directors
15 mars 2023 07h00 HE
|
Proxygen
VIENNA, Austria, March 15, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced the formation of the company’s board of...